All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-27182775

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	27182775	T131N	S	S	Occult HBV Infection	G R S I C L	View
2	27182775	115_116ins	S	S	Occult HBV Infection	G R S I C L	View
3	27182775	122_123ins	S	S	Occult HBV Infection	G R S I C L	View
4	27182775	126_127ins	S	S	Occult HBV Infection	G R S I C L	View
5	27182775	131_133ins	S	S	Occult HBV Infection	G R S I C L	View
6	27182775	2848_2862del	S	S	Occult HBV Infection	G R S I C L	View
7	27182775	3014_3198del	PreS1	S	Occult HBV Infection	G R S C L	View
8	27182775	3046_3177del	PreS1	S	Occult HBV Infection	G R S C L	View
9	27182775	3115_3123del	PreS1	S	Occult HBV Infection	G R S C L	View
10	27182775	G145R	S	S	Occult HBV Infection	G R S I C L	View
11	27182775	I126V	S	S	Occult HBV Infection	G R S I C L	View
12	27182775	Q129N	S	S	Occult HBV Infection	G R S I C L	View
13	27182775	T126V	S	S	Occult HBV Infection	G R S I C L	View
14	27182775	M133T	S	S	Occult HBV Infection	G R S I C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.